Literature DB >> 11903856

Slow release caffeine and prolonged (64-h) continuous wakefulness: effects on vigilance and cognitive performance.

M Beaumont1, D Batejat, C Pierard, O Coste, P Doireau, P Van Beers, F Chauffard, D Chassard, M Enslen, J B Denis, D Lagarde.   

Abstract

Some long work or shift work schedules necessitate an elevated and prolonged level of vigilance and performance but often result in sleep deprivation (SD), fatigue and sleepiness, which may impair efficiency. This study investigated the effects of a slow-release caffeine [(SRC) at the daily dose of 600 mg] on vigilance and cognitive performance during a 64 h continuous wakefulness period. Sixteen healthy males volunteered for this double-blind, randomised, placebo controlled, two-way crossover study. A total of 300-mg SRC or placebo (PBO) was given twice a day at 21:00 and 9:00 h during the SD period. Vigilance was objectively assessed with continuous electroencephalogram (EEG), the multiple sleep latency tests (MSLT) and wrist actigraphy. Cognitive functions (information processing and working memory), selective and divided attention were determined with computerised tests from the AGARD-NATO STRES Battery (Standardised Tests for Research with Environmental Stressors). Attention was also assessed with a symbol cancellation task and a Stroop's test; alertness was appreciated from visual analogue scales (VAS). Tests were performed at the hypo (02:00-04:00 h, 14:00-16:00 h) and hypervigilance (10:00-12:00 h, 22:00-00:00 h) periods during SD. Central temperature was continuously measured and safety of treatment was assessed from repeated clinical examinations. Compared with PBO, MSLT showed that SRC subjects were more vigilant from the onset (P=0.001) to the end of SD (P < 0.0001) whereas some cognitive functions were improved till the thirty third of SD but others were ameliorated through all the SD period and alertness was better from the thirteenth hour of SD, as shown by Stroop's test (P=0.048). We showed that 300-mg SRC given twice daily during a 64-h SD is able to antagonize the impairment produced on vigilance and cognitive functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11903856     DOI: 10.1046/j.1365-2869.2001.00266.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  16 in total

Review 1.  Vigilance, alertness, or sustained attention: physiological basis and measurement.

Authors:  B S Oken; M C Salinsky; S M Elsas
Journal:  Clin Neurophysiol       Date:  2006-04-03       Impact factor: 3.708

2.  Suppression of hippocampal cell proliferation by short-term stimulant drug administration in adult rats.

Authors:  Linda J Kochman; Casimir A Fornal; Barry L Jacobs
Journal:  Eur J Neurosci       Date:  2009-06-01       Impact factor: 3.386

3.  Effects of time-release caffeine containing supplement on metabolic rate, glycerol concentration and performance.

Authors:  Adam M Gonzalez; Jay R Hoffman; Adam J Wells; Gerald T Mangine; Jeremy R Townsend; Adam R Jajtner; Ran Wang; Amelia A Miramonti; Gabriel J Pruna; Michael B LaMonica; Jonathan D Bohner; Mattan W Hoffman; Leonardo P Oliveira; David H Fukuda; Maren S Fragala; Jeffrey R Stout
Journal:  J Sports Sci Med       Date:  2015-05-08       Impact factor: 2.988

Review 4.  Cumulative neurobehavioral and physiological effects of chronic caffeine intake: individual differences and implications for the use of caffeinated energy products.

Authors:  Andrea M Spaeth; Namni Goel; David F Dinges
Journal:  Nutr Rev       Date:  2014-10       Impact factor: 7.110

5.  Benefits of Sleep Extension on Sustained Attention and Sleep Pressure Before and During Total Sleep Deprivation and Recovery.

Authors:  Pierrick J Arnal; Fabien Sauvet; Damien Leger; Pascal van Beers; Virginie Bayon; Clément Bougard; Arnaud Rabat; Guillaume Y Millet; Mounir Chennaoui
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

6.  Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work.

Authors:  Carl L Hart; Amie S Ward; Margaret Haney; Jennifer Nasser; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2003-05-07       Impact factor: 4.530

7.  Effects of caffeine on alertness as measured by infrared reflectance oculography.

Authors:  Natalie Michael; Murray Johns; Caroline Owen; John Patterson
Journal:  Psychopharmacology (Berl)       Date:  2008-06-09       Impact factor: 4.530

8.  Caffeine does not entrain the circadian clock but improves daytime alertness in blind patients with non-24-hour rhythms.

Authors:  Melissa A St Hilaire; Steven W Lockley
Journal:  Sleep Med       Date:  2015-02-11       Impact factor: 3.492

9.  Caffeine improves reaction time, vigilance and logical reasoning during extended periods with restricted opportunities for sleep.

Authors:  Gary H Kamimori; Tom M McLellan; Charmaine M Tate; David M Voss; Phil Niro; Harris R Lieberman
Journal:  Psychopharmacology (Berl)       Date:  2014-12-21       Impact factor: 4.530

10.  Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates.

Authors:  Linda J Porrino; James B Daunais; Gary A Rogers; Robert E Hampson; Sam A Deadwyler
Journal:  PLoS Biol       Date:  2005-08-23       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.